Pharmacopsychiatry

Issue 01 · January 2005

eFirst
Issue
A joint meeting of the AGNP-TDM Group, of the Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie (AGNP) (Association of Neuropsychopharmacology and Pharmacopsychiatry) and the SGAMSP (Schweizerische Gesellschaft für Arzneimittelsicherheit in der Psychiatrie/Société suisse de pharmacovigilance en psychiatrie/Swiss Society of Pharmacovigilance in Psychiatry) in collaboration with the AMSP e.V., Germany (German Society of Pharmacovigilance in Psychiatry) and ÖAMSP (Austrian Society of Pharmacovigilance in Psychiatry)
International Meeting on Pharmacovigilance in Psychiatry, Therapeutic Drug Monitoring and Pharmacogenetics of Psychotropic Drugs
Lausanne, Switzerland, September 1–3, 2004

Pierre Baumann, Prilly-Lausanne, Switzerland, and Josef Aldenhoff, Kiel, Germany

Abstracts (HTML) List of Authors
Original Paper
Original Paper
1
Bücheler, R.; Gleiter, C. H.; Schwoerer, P.; Gaertner, I.: Use of Nonprohibited Hallucinogenic Plants: Increasing Relevance for Public health?

Full Text

HTML

PDF (71 kb)
6
Kluge, M.; Wehmeier, P. M.; Dittmann, R. W.; Langer, F.; Czekalla, J.; Lehmann, M.; Keßler, F. H.; Beyenburg, S.; Naber, D.: A Simple Switching Strategy for Inadequately Treated Patients with Schizophrenia to Olanzapine: Changes in Psychopathology and Subjective Well-being

Full Text

HTML

PDF (135 kb)
13
Wehmeier, P. M.; Kluge, M.; Maras, A.; Riemann, D.; Berger, M.; Kohnen, R.; Dittmann, R. W.; Gattaz, W. F.: Fluoxetine Versus Trimipramine in the Treatment of Depression in Geriatric Patients

Full Text

HTML

PDF (61 kb)
17
Nakajima, M.; Terao, T.; Iwata, N.; Nakamura, J.: Switching Female Schizophrenic Patients to Quetiapine from Conventional Antipsychotic Drugs: Effects on Hyperprolactinemia

Full Text

HTML

PDF (52 kb)
24
Kronenberg, G.; Berger, P.; Tauber, R. F.; Bandelow, B.; Henkel, V.; Heuser, I.: Randomized, Double-Blind Study of SR142801 (Osanetant). A Novel Neurokinin-3 (NK3) Receptor Antagonist in Panic Disorder with Pre- and Posttreatment Cholecystokinin Tetrapeptide (CCK-4) Challenges

Full Text

HTML

PDF (122 kb)
30
Otsubo, T.; Akimoto, Y.; Yamada, H.; Koda, R.; Aoyama, H.; Tanaka, K.; Mimura, M.; Nakagome, K.; Kamijima, K.: A Comparative Study of the Efficacy and Safety Profiles Between Fluvoxamine and Nortriptyline in Japanese Patients with Major Depression

Full Text

HTML

PDF (97 kb)
Review
20
Grootens, K. P.; Verkes, R. J.: Emerging Evidence for the Use of Atypical Antipsychotics in Borderline Personality Disorder

Full Text

HTML

PDF (61 kb)
Letter
36
Baumgart, U.; Schmid, R.; Spießl, H.: Olanzapine-Induced Acute Rhabdomyolysis

Full Text

HTML

PDF (62 kb)
38
Croissant, B.; Hermann, D.; Olbrich, R.: Reduction of Side Effects by Combining Clozapine with Amisulpride: Case Report and Short Review of Clozapine-Induced Hypersalivation

Full Text

HTML

PDF (37 kb)
39
Kämpf, P.; Agelink, M. W.; Naber, D.: Augmentation of Clozapine with Amisulpride: A Promising Therapeutic Approach to Refractory Schizophrenic Symptoms

Full Text

HTML

PDF (32 kb)
Most Read
Archive
Free Sample Issue

Journal

Authors

Subscription

AGNP

Collections